Complications After Endosonography and Guided Bronchoscopy

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Other)
Overall Status
Completed
CT.gov ID
NCT04621344
Collaborator
(none)
701
1
16.3
42.9

Study Details

Study Description

Brief Summary

The present study aims to investigate prospectively and systematically the direct and indirect complications occurring within 30 days after guided-bronchoscopy and/or endosonography. The results of the study should reliably help clarify further incidence, pattern, risk factors, and outcomes for both immediate and late complications associated with these key diagnostic procedures.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Guided bronchoscopy and/or endosonography

Study Design

Study Type:
Observational
Actual Enrollment :
701 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
30-DAY MORBIDITY, MORTALITY AND UNPLANNED HOSPITAL ADMISSIONS AFTER GUIDED-BRONCHOSCOPY AND ENDOSONOGRAPHY
Actual Study Start Date :
Oct 27, 2020
Actual Primary Completion Date :
Feb 7, 2022
Actual Study Completion Date :
Mar 8, 2022

Outcome Measures

Primary Outcome Measures

  1. Incidence of severe complications [30 days]

Secondary Outcome Measures

  1. Overall incidence of complications [30 days]

  2. Risk factors associated with severe complications [30 days]

  3. Rate of unplanned hospital admissions [30 days]

  4. Mortality [30 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age >18 years,

  • Indication to undergo bronchoscopy, endosonography, or both.

  • Signed informed consent

Exclusion Criteria:
  • Absolute contraindications to the bronchoscopic examination based on international guidelines [31].

  • Platelet count <50000

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Lazio Italy 00168

Sponsors and Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Investigators

  • Principal Investigator: Rocco Trisolini, MD, Fondazione Policlinico Universitario A. Gemelli IRCS, Università Cattolica del Sacro Cuore

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ClinicalTrials.gov Identifier:
NCT04621344
Other Study ID Numbers:
  • ST1
First Posted:
Nov 9, 2020
Last Update Posted:
Apr 14, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Study Results

No Results Posted as of Apr 14, 2022